Axon Enterprise, Inc $AXON Stock Position Lowered by Jacksonville Wealth Management LLC

Jacksonville Wealth Management LLC lessened its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 2.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,717 shares of the biotechnology company’s stock after selling 134 shares during the period. Axon Enterprise comprises approximately 3.1% of Jacksonville Wealth Management LLC’s investment portfolio, making the stock its 7th biggest holding. Jacksonville Wealth Management LLC’s holdings in Axon Enterprise were worth $3,905,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Westside Investment Management Inc. lifted its holdings in shares of Axon Enterprise by 4.8% in the 2nd quarter. Westside Investment Management Inc. now owns 283 shares of the biotechnology company’s stock worth $225,000 after buying an additional 13 shares during the period. CVA Family Office LLC raised its holdings in shares of Axon Enterprise by 26.9% in the second quarter. CVA Family Office LLC now owns 66 shares of the biotechnology company’s stock valued at $55,000 after acquiring an additional 14 shares in the last quarter. LaSalle St. Investment Advisors LLC raised its holdings in shares of Axon Enterprise by 2.1% in the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company’s stock valued at $408,000 after acquiring an additional 16 shares in the last quarter. STF Management LP lifted its stake in Axon Enterprise by 1.4% in the second quarter. STF Management LP now owns 1,164 shares of the biotechnology company’s stock worth $964,000 after acquiring an additional 16 shares during the period. Finally, Hemington Wealth Management grew its holdings in Axon Enterprise by 70.8% during the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 17 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on AXON. Needham & Company LLC restated a “buy” rating and issued a $870.00 price target on shares of Axon Enterprise in a report on Wednesday, September 24th. The Goldman Sachs Group reduced their price objective on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a research note on Wednesday, November 5th. JMP Securities restated a “market outperform” rating and set a $825.00 target price on shares of Axon Enterprise in a report on Monday, September 29th. Piper Sandler cut their price target on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. Finally, Northland Securities set a $800.00 price target on Axon Enterprise in a research report on Tuesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $810.71.

Insiders Place Their Bets

In related news, CAO Jennifer H. Mak sold 77 shares of the stock in a transaction that occurred on Monday, September 15th. The shares were sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the transaction, the chief accounting officer directly owned 15,003 shares of the company’s stock, valued at $11,402,280. This trade represents a 0.51% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $591.04, for a total transaction of $5,910,400.00. Following the completion of the sale, the chief executive officer owned 3,023,982 shares of the company’s stock, valued at $1,787,294,321.28. This trade represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 38,622 shares of company stock worth $26,439,364 in the last three months. Insiders own 5.70% of the company’s stock.

Axon Enterprise Price Performance

NASDAQ AXON opened at $557.29 on Friday. The firm’s fifty day simple moving average is $706.36 and its two-hundred day simple moving average is $734.49. The firm has a market capitalization of $43.98 billion, a P/E ratio of 137.60, a P/E/G ratio of 29.49 and a beta of 1.45. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 12-month low of $469.24 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $710.64 million for the quarter, compared to analysts’ expectations of $704.83 million. During the same quarter in the prior year, the company posted $1.45 EPS. The business’s revenue for the quarter was up 30.6% on a year-over-year basis. Analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.